SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is currently trending as retail investors rally behind heavy institutional buying, with firms like Morgan Stanley significantly increasing their positions ahead of a busy schedule of oncology conferences. The market is hyper-focused on the company's REGAL clinical trial reaching 78 of 80 required events, fueling community speculation about a looming data readout and potential M&A activity.

T1 Energy, Inc. engages in developing battery solutions. It focuses on energy storage systems and commercial mobility. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

Technip Energies is capturing market attention as the company gains momentum with major engineering contracts and positive operational news, fueling community excitement about its growth in the U.S. manufacturing and energy infrastructure sector. Investors are closely monitoring the stock as sentiment shifts, with many actively discussing potential setups, analyst target revisions, and the company's positioning within the broader renewable energy and power grid evolution.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is currently trending due to a combination of heavy institutional scrutiny, ongoing AI monetization concerns following an analyst downgrade, and community debate over the company's valuation as a 'cash machine' versus its growth prospects. Investors are actively discussing the stock's potential as a long-term value play supported by a massive buyback program, while others fear that AI agents may disrupt its traditional subscription-based business model.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike Inc is experiencing intense selling pressure, with the stock trading at multi-year lows as market participants express deep skepticism over its turnaround efforts, leadership, and loss of market share. While some retail traders are betting on a recovery fueled by upcoming catalysts like the World Cup and potential tariff relief, many others are aggressively shorting the name, citing concerns over inventory, declining demand, and a perceived loss of brand resonance.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending as investors react to a new executive order aimed at fast-tracking psychedelic drug research and streamlining regulatory reviews through priority vouchers. The community is actively discussing the stock's role as a potential first-mover in the treatment-resistant depression market, with many focused on the upcoming release of pivotal trial data and speculation regarding long-term acquisition interest from major pharmaceutical players.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is facing significant volatility following a wider-than-expected net loss and missed revenue targets, though the companys raised forward guidance and strategic shift toward branded GLP-1 distributions have sparked debate. Community discourse remains deeply divided between those viewing the pullback as a buying opportunity based on long-term growth in peptides and personalized healthcare, and skeptics who remain concerned about margin compression and the sustainability of the company's valuation.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending as investors react to the launch of 'Ford Energy,' a new subsidiary focusing on battery energy-storage systems for data centers and industrial customers to capture AI-driven power demand. The community is actively debating whether this strategic pivot marks a valuation re-rating that transforms the legacy automaker into a high-growth AI infrastructure play.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is trending as the community actively debates its positioning in the Chinese AI and cloud infrastructure sector following mixed Q1 earnings and ongoing interest in its robotaxi and agentic AI initiatives. While some investors remain cautious about legacy ad revenue declines and geopolitical volatility, bullish sentiment persists around the company's long-term potential to capitalize on domestic AI demand and potential value realization from its subsidiary spinoffs.

Dominion Energy, Inc. engages in the production and distribution of energy. It operates through following business segments: Dominion Energy Virginia, Dominion Energy South Carolina, Contracted Energy, and Corporate and Other. The Corporate and Other segment focuses on corporate, service company, non-controlling interest in Dominion privatization, and non-regulated retail energy marketing operations. The company was founded by William W. Berry in 1983 and is headquartered in Richmond, VA.

Dominion Energy Inc

Dominion Energy is trending due to reports that NextEra Energy is in advanced talks to acquire the utility in a deal valued at approximately $66 billion, a move driven by the massive surge in electricity demand from AI and data center expansion. The community is actively debating the potential regulatory and antitrust hurdles for such a large-scale merger, while also discussing the impact on dividend consistency and the strategic fit of integrating Dominion's infrastructure into NextEra's portfolio.

LiveRamp Holdings, Inc. is a global technology company, which engages in the provision of a data collaboration platform in consumer privacy, data ethics, and foundational identity. The company was founded in 1969 and is headquartered in San Francisco, CA.

LiveRamp Holdings Inc

LiveRamp is trending following an acquisition agreement by Publicis, a move that the investment community is analyzing as a significant shift toward agency-owned data infrastructure. While some investors are debating the deal's valuation and the resulting arbitrage opportunities, many are actively discussing the broader implications for the ad-tech landscape and the impact on long-term shareholders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cipla, Pfizer ink partnership for exclusive marketing of four brands in India

Pfizer India and Cipla Limited have announced a strategic partnership where Cipla will exclusively market and distribute four of Pfizer's key brands in India. This collaboration aims to leverage Cipla's extensive distribution network to enhance patient access to essential medicines like Corex Dx, Dolonex, Neksium, and Dalacin C across the country.

Vietnam's Visionary Leaders Redefine Success at the Asia Pacific Enterprise Awards 2025

HO CHI MINH CITY, Vietnam , Oct. 10, 2025 /PRNewswire/ -- Vietnam's most visionary leaders and trailblazing enterprises took center stage at the Asia Pacific Enterprise Awards (APEA) 2025 Vietnam, held on 9 October 2025 at the GEM Center, Ho Chi Minh City . Organized by leading regional NGO Enterprise Asia, the prestigious awards program honored businesses and business leaders who are reshaping industries, embracing innovation, and driving sustainable growth. Vietnam’s Visionary Leaders Redefine Success at the Asia Pacific Enterprise Awards 2025 With the theme 'Showcasing Future-Ready Enterprises', this year's APEA celebrated organizations and leaders who are future-proofing their businesses amidst sweeping technological disruption and shifting economic landscapes. A highly selective judging process evaluated 342 nominees across four award categories: Master Entrepreneur, Inspirational Brand, Fast Enterprise, and Corporate Excellence. Each recipient stood out for their resilience, innovation, and commitment to creating lasting impact.

Indian equity markets snapped their eight-day losing streak, with the Nifty index reclaiming 24,800, driven by a 700-point rally in Nifty Bank. This came after the Reserve Bank of India held steady on repo rates and revised inflation forecasts lower. The central bank also announced a slew of reforms for the banking space, including increased loan limits.On Wednesday, the Sensex closed 715 points higher at 80,983, while the&nbsp;<a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50</a> ended up 225 points at 24,836. Broader markets mirrored the optimism, with the Nifty Midcap index rising 0.8% and the Smallcap index gaining 1.1%.However, the retail investor sentiment surrounding the Nifty 50 remained ‘bearish’ by market close on Stocktwits.<figure class="image"><img style="aspect-ratio:813/102;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_01_155746_png_5955436f5e.webp" alt="Screenshot 2025-10-01 155746.png" width="813" height="102"><figcaption>Nifty sentiment and message volume on Oct 1 as of 3:50 pm IST. | source: Stocktwits</figcaption></figure>Stock MovesSectorally, barring PSU banks, all indices ended in the green. Media (+4%), pharmaceuticals (+1.2%), and real estate (+1%) saw strong buying. A notable mover in the media space was Sun TV, which closed with 12% gains.Kotak Mahindra Bank, Axis Bank, ICICI Bank, and HDFC Bank were among the top Nifty gainers, driven by the RBI’s reforms push.&nbsp;<a href="https://stocktwits.com/symbol/TATAMOTORS.NSE">Tata Motors</a> ended over 5% higher after its <a href="https://stocktwits.com/news-articles/markets/equity/tata-motors-demerger-takes-effect-retail-investors-to-benefit-says-analyst/chCor1mR39A">demerger</a> came into effect; the record date has been set at October 14.<a href="https://stocktwits.com/symbol/PFIZER.NSE">Pfizer India</a> rose 3% after US President Donald Trump announced a deal with the American parent company to provide key prescription medications at steeply discounted prices through a new government-run online platform. The rest of the pharmaceutical space also saw a relief rally, with Sun Pharma and Lupin gaining 3%.&nbsp;Shriram Finance gained 5% after the company shot down reports that Japan’s Mitsubishi UFJ Financial Group (MUFG) was in talks to buy a 20% stake worth ₹23,200 crore.Stock Calls<a href="https://stocktwits.com/equitycharcha">Ashok Kumar Aggarwal of Equity Charcha</a> is bullish on TVS Supply Chain Solutions. It recently inaugurated a new facility in Iowa (USA) to support local manufacturing. On its technical charts, he noted that its Relative Strength Index (RSI) was ranging between 37 and 45 on its daily, weekly, and monthly time frame charts.&nbsp;He shared a short-to-medium term trade call on TVS Supply with an accumulation zone between ₹124-₹126 with a stop loss at ₹118 on a closing basis. The short-term target is set at ₹142, and a medium-term target price is ₹161.<stembedurl>https://stocktwits.com/equitycharcha/message/630578691</stembedurl><a href="https://stocktwits.com/Ca_mayankchandel">Mayank Singh Chandel</a> shared a swing trade call on&nbsp;<a href="https://stocktwits.com/symbol/HINDZINC.NSE">Hindustan Zinc</a>. He noted that the stock was consolidating near the gap resistance at ₹483.05, with rising volumes indicating strong upside interest. Chandel recommended a buy on a close above ₹483.05, with a stop loss at ₹463 and a target price of ₹535.<stembedurl>https://stocktwits.com/Ca_mayankchandel/message/630585738</stembedurl>Markets: What Next?<a href="https://stocktwits.com/WealthFino">Krishna Pathak&nbsp;</a>highlighted Nifty support near the 24,540–24,600 zone, with immediate resistance around the 24,800–24,900 levels. He added that the index was trading above the 9-day Exponential Moving Average (EMA), which indicates a short-term bullish momentum. If it breaks out above 24,800, it could open the path towards 24,900–25,100. But sustained weakness below 24,600 can extend declines towards 24,540.<stembedurl>https://stocktwits.com/WealthFino/message/630580092</stembedurl>Globally, European markets traded higher, while US stock futures indicate a weak start on Wall Street after a deadlock over healthcare and government spending led to the US government shutdown for a first time in nearly seven years.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

(Photo by Indranil Aditya/NurPhoto via Getty Images)

Banking Rally Lifts Indian Markets: RBI Policy Boosts Nifty To 24,800, Sensex Ends Near 81,000

Benchmarks staged a strong comeback on RBI’s supportive policy measures, though retail sentiment on Nifty 50 remained ‘bearish’ on Stocktwits.

Equity

Shares of Pfizer, the Indian arm of U.S.-based Pfizer Inc., rose more than 2% on Wednesday after President Donald Trump announced a deal with the drugmaker to provide key prescription medications at steeply discounted prices through a new government-run online platform, ‘TrumpRX.’Deal AnnouncementSpeaking at the White House, Trump said Pfizer agreed to supply several of its most widely used drugs at “heavily discounted prices of anywhere between 50% and even 100%,” allowing patients to pay cash directly on the new TrumpRX website.&nbsp;He added that all new Pfizer drugs introduced in the U.S. will be sold at “most favored patient costs,” ensuring prices are comparable to the lowest charged internationally.Pfizer CEO Albert Bourla said the company’s deal with the Trump administration satisfies all of the President’s requirements.&nbsp;He added that Pfizer has secured a three-year grace period from proposed tariffs on pharmaceutical imports, while also cutting prices on certain drugs. “The President is absolutely right—tariffs are the most powerful tool to motivate behavior, and they clearly motivated ours,” Bourla said.Trump also warned that companies refusing to lower prices could face additional tariffs of 5% to 8%, as his administration continues to pressure drugmakers to expand U.S.-based production before Oct. 1, 2025.Analyst ViewSEBI-registered analyst Sunil Kotak said that Pfizer’s daily chart shows a sideways trend, with the 50-day simple moving average (SMA) around ₹5,200 and a strong supply zone between ₹5,200–₹5,300.&nbsp;<stembedurl>https://stocktwits.com/Technofunda24/message/630578299</stembedurl>He noted that the stock would need to close above ₹5,300 for a fresh up-move, while the relative strength index (RSI) stands at 52, indicating consolidation for now.What Is The Retail Mood?On Stocktwits, retail sentiment for Pfizer was ‘bullish’ amid ‘high’ message volume.<a href="https://stocktwits.com/symbol/PFIZER.NSE">Pfizer’s stock</a> has declined 2.8% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, Pfizer’s logo is on a smartphone with an economic stock exchange index graph in the background. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images)

Pfizer India Rises On Trump’s Drug Discount Deal — SEBI Analyst Eyes Breakout Above ₹5,300

Pfizer shares rose after the U.S. drugmaker struck a deal with the Trump administration to sell key medicines at steep discounts through a new federal website.

Indian equity markets have opened on a positive note as investors await the rate decision from India’s central bank. The street is expecting the Reserve Bank of India (RBI) to maintain a status quo with a dovish tone, but some expect a 25 bps rate cut.At 09:40 a.m. IST, the&nbsp;<a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50</a> traded 59 points higher at 24,670, while the Sensex was up 182 points at 80,450. Broader markets were mixed, with the Nifty Midcap index rising 0.2% and Smallcap index trading flat.The retail sentiment on Stocktwits for the Nifty remained ‘bearish’ at market open.&nbsp;<figure class="image"><img style="aspect-ratio:802/94;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_01_094251_png_63cb54d831.webp" alt="Screenshot 2025-10-01 094251.png" width="802" height="94"><figcaption>Nifty sentiment and message volume on Oct 1 as of 9:40 am IST. | source: Stocktwits</figcaption></figure>Stock WatchSectorally, barring IT and PSU banks, rest of the sectors traded in the green, led by media, pharmaceuticals, real estate and autos.&nbsp;Shriram Finance rose over 2% as news reports suggest that Japan's MUFG is looking to buy a 20% stake in the company.&nbsp;Tata Motors rose 1% as its long-awaited demerger into passenger and commercial vehicle units takes effect today. <a href="https://stocktwits.com/symbol/TATAINVEST.NSE">Tata Investment</a> continues its bull run, with 4% gains in opening trade. Tata Sons, the holding company of Tata Group, holds a 0.10% stake in Tata Investment and has missed a regulatory deadline to become publicly listed as per RBI norms for NBFCs.&nbsp;<a href="https://stocktwits.com/symbol/PFIZER.NSE">Pfizer India shares</a> surged 5% after its US parent company received a three-year reprieve from tariffs on pharmaceutical imports imposed by US President Donald Trump.Lupin gained 3% following a USFDA nod for Rivaroxaban oral suspension drug, used to treat venous thromboembolism (VTE).<a href="https://stocktwits.com/symbol/RATEGAIN.NSE">RateGain shares</a> fell 3% as the company is considering acquiring Sojern and its subsidiaries through its wholly-owned subsidiary for $250 million.Newgen Software rose 2% on securing multiple deals across the UK, US, Ghana, and Dubai, with total contract wins exceeding $9 million. RITES too gained over 2% following a pact with Etihad Rail.&nbsp;Atlantaa shares surged 20% after the company entered into an agreement with IRCON International for undertaking a contract worth ₹2,485 crore.Stock CallsAnalyst&nbsp;<a href="https://stocktwits.com/Wisebull_co_in">Vinayak Gautam</a> shared three stock recommendations for Wednesday with a 1-week timeframe:<a href="https://stocktwits.com/symbol/JSWSTEEL.NSE">JSW Steel</a>: Buy at ₹1,142, with a target price of ₹1,164, and stop loss at ₹1,130<a href="https://stocktwits.com/symbol/RITES.NSE">RITES</a>: Buy at ₹246.04, with a target price of ₹254, and stop loss at ₹243<a href="https://stocktwits.com/symbol/AGIIL.NSE">Agi Infra</a>: Buy at ₹1,260, with a target price of ₹1280, and stop loss at ₹1,250<stembedurl>https://stocktwits.com/Wisebull_co_in/message/630573311</stembedurl>Markets: The Road AheadFrom a technical standpoint, SEBI-registered analysts on Stocktwits shared the trade setup.&nbsp;Analyst&nbsp;<a href="https://stocktwits.com/kyalashish">Ashish Kyal</a> said the Nifty index is managing to show reduced momentum on the downside, but has yet to see a close above the prior high. For Wednesday, a break below 24,580 can take prices to 24,520-24,480 levels. A close above<a href="https://stocktwits.com/topic/Gann">&nbsp;</a>Gann levels of 24,728 on a 15-minute timeframe is required to resume a positive trend to 24,780-24,820. A move is expected 10 minutes after the RBI policy decision.<stembedurl>https://stocktwits.com/kyalashish/message/630572014</stembedurl><a href="https://stocktwits.com/prabhatmittal1">Prabhat Mittal</a> identified Nifty support at 24,450 with resistance at 24,850. For Bank Nifty, he sees support at 54,300 and resistance at 54,900.<stembedurl>https://stocktwits.com/prabhatmittal1/message/630571237</stembedurl>Global CuesGlobally, Asian markets traded mostly higher, while crude oil prices held steady.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Indian Markets Open Firm Ahead Of RBI Policy; Tata Investment, Pfizer, Shriram Finance Gain Ground

 Pharma, autos, and media stocks led early gains, while Tata Motors and Atlantaa were among top movers.

Indian stocks are poised for a subdued opening on Wednesday, as the GIFT Nifty — an early indicator for the Nifty 50 index — traded flat ahead of the market open. Benchmark indexes ended lower for the eighth straight session on Tuesday, with the Nifty index closing below 24,700.All eyes will also be on the Reserve Bank of India’s (RBI) rate decision due at 10 am today. Economists expect the central bank to hold steady on rates but a dovish tone could open the path for further rate cuts going forward. Rate sensitive sectors will be in focus today.&nbsp;Most major Asian markets were mostly higher in morning trade, barring Japanese Nikkei that was down nearly 1%. Chinese markets are shut for a week for National Day holidays.Stock WatchPfizer India: The US parent company has received a three-year reprieve from tariffs on pharmaceutical imports imposed by US President Donald Trump.Aurobindo, Dr Reddy’s, other Indian pharma companies: Trump's 100% tariff on pharma takes effect todayLupin - Got USFDA nod for Rivaroxaban oral suspension drug, used to treat venous thromboembolism (VTE).Auto stocks - Investors will be tracking September sales data.Shriram Finance - News reports suggest that Japan's MUFG is looking to buy 20% stake in the company.&nbsp;Nestle India - Has signed a Memorandum of Understanding (MoU) to boost investments in Odisha &amp; existing plants.Shree Cement - The company commissioned 3.65 MTPA clinkerisation unit in Rajasthan.Indian Overseas Bank - Got ₹31.8 lakh penalty notice from RBI for non-compliance of its Priority Sector Lending (PSL) targets and classification norms.OIL India &amp; GAIL - signed a pact to boost collaboration across the natural gas value chainRateGain - The company is considering acquiring Sojern and its subsidiaries through its wholly-owned subsidiary for $250 million.Newgen Software - Company has signed multiple deals across the UK, US, Ghana, and Dubai, with total contract wins exceeding $9 million.RITES - The company has signed a pact with Etihad Rail and its subsidiary to boost collaboration in the mobility sector across the UAE.&nbsp;Atlantaa - The company has entered into an agreement with IRCON International for undertaking a contract worth ₹2,485 crore.Swan Defence has signed a Memorandum of Understanding (MoU) with Samsung Heavy Industries to jointly explore commercial shipbuilding and heavy engineering projects across domestic and international markets.Mainboard Listing Today&nbsp;Epack Prefab Technologies, BMW Ventures, and Jain Resource RecyclingFor updates and corrections, email newsroom[at]stocktwits[dot]com.

The digital broadcast on the facade of the Bombay Stock Exchange (BSE) displays the benchmark share index SENSEX crossing 32,000 points, on July 13, 2017 in Mumbai, India. (Photo by Kunal Patil/Hindustan Times via Getty Images)

Sensex, Nifty Poised For Quiet Start; Pfizer, Lupin, Tata Motors, RateGain, Newgen, RITES On Stock Watchlist

 After eight days of losses, markets may see a cautious start as the RBI policy decision takes center stage. Stock-specific action is expected in pharma, auto, and PSU banking counters.

DPIIT partners with Pfizer to boost lab-to-market pathway for healthcare innovation

New Delhi, Sep 4 : The Department for Promotion of Industry and Internal Trade (DPIIT) has signed a Memorandum of Understanding (MoU) with US-based pharma giant Pfizer to strengthen Indias healthcare and accelerate the lab-to-market journey of healthcare innovations, the Ministry of Commerce and Industry said on Thursday. The collaboration will extend both financial and non-financial support to startups. Under the partnership, the Pfizer INDovation programme will empower DPIIT-recognised startups with grants of up to Rs 60 lakhs each, along with a tailored 18-month incubation programme delivered by Social Alpha. The programme will provide dedicated acceleration tracks covering clinical validation, regulatory approvals, and go-to-market strategies. Startups will also gain access to expert mentorship, infrastructure, and global networks, in addition to exposure at Pfizers Research and Development facilities in Chennai, enabling them to strengthen innovations with advanced industry insights, the Ministry said.

Pfizer Ltd. engages in the business of manufacturing, marketing, trading, import and export of pharmaceutical products. Its product offerings include treatment for depression, erectile dysfunction, high cholesterol, human immunodeficiency virus infection, hypertension, bacterial infections and systemic fungal infections, and other chronic therapeutic which includes pain, respiratory, vitamins or minerals, hospital anti-infectives, neurosciences, and cardiovascular. The firm's products include Prevenar 13, Ativan, Zosyn, Minipress XL, Meronem, Enbrel, Dolonex, Magnex, Trulimax, Neksium, Becosules, Gelusil, Mucaine, Folvite, Autrin, Citralka, and Corex Range. It operates through the India and Outside of India geographical segments. The company was founded on November 21, 1950 and is headquartered in Mumbai, India.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '25	34.70	41.90	20.75%	BEAT
Q4 '24	35.85	--	--	N/A
Q3 '24	31.80	--	--	N/A
Q2 '24	37.00	--	--	N/A

PFIZER.NSE
Pfizer Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '25

Historical Earnings

Latest PFIZER.NSE News

PFIZER.NSEPfizer Ltd.